2020
DOI: 10.3390/molecules25194446
|View full text |Cite
|
Sign up to set email alerts
|

Hetiamacin E and F, New Amicoumacin Antibiotics from Bacillus subtilis PJS Using MS/MS-Based Molecular Networking

Abstract: To combat escalating levels of antibiotic resistance, novel strategies are developed to address the everlasting demand for new antibiotics. This study aimed at investigating amicoumacin antibiotics from the desert-derived Bacillus subtilis PJS by using the modern MS/MS-based molecular networking approach. Two new amicoumacins, namely hetiamacin E (1) and hetiamacin F (2), were finally isolated. The planar structures were determined by analysis of extensive NMR spectroscopic and HR–ESI–MS data, and the absolute… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
12
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
3
1

Relationship

1
8

Authors

Journals

citations
Cited by 19 publications
(12 citation statements)
references
References 40 publications
0
12
0
Order By: Relevance
“…As a biosensor of antimicrobial activity, the described assay was reported to be successfully applied for identification of a series of promising antibiotics whose antibacterial activity had not been reported previously, such as 2-Guanidino-quinazolines ( Komarova et al, 2017 ), N-pyridyl-substituted carboxypiperidine amides ( Ivanenkov et al, 2019b ), and N-substituted triazolo-azetidines ( Ivanenkov et al, 2019c ). Furthermore, in our previous study, this platform contributed to effective discovery of some novel antibiotics that act via the translation inhibition mechanism, such as Beilunmycin ( Jiang et al, 2020 ), Hetiamacin E and F ( Wang et al, 2020b ), acetyl-griseoviridin, and desulphurizing griseoviridin ( Wang et al, 2020a ). In the present research, two Streptomyces strains and two Saccharothrix strains induced Katushka2S expression, demonstrating the protein inhibitory activities in their ethyl acetate extractions.…”
Section: Discussionmentioning
confidence: 99%
“…As a biosensor of antimicrobial activity, the described assay was reported to be successfully applied for identification of a series of promising antibiotics whose antibacterial activity had not been reported previously, such as 2-Guanidino-quinazolines ( Komarova et al, 2017 ), N-pyridyl-substituted carboxypiperidine amides ( Ivanenkov et al, 2019b ), and N-substituted triazolo-azetidines ( Ivanenkov et al, 2019c ). Furthermore, in our previous study, this platform contributed to effective discovery of some novel antibiotics that act via the translation inhibition mechanism, such as Beilunmycin ( Jiang et al, 2020 ), Hetiamacin E and F ( Wang et al, 2020b ), acetyl-griseoviridin, and desulphurizing griseoviridin ( Wang et al, 2020a ). In the present research, two Streptomyces strains and two Saccharothrix strains induced Katushka2S expression, demonstrating the protein inhibitory activities in their ethyl acetate extractions.…”
Section: Discussionmentioning
confidence: 99%
“…In contrast, thiocillin targets the gram-negative bacterium Pseudomonas aeruginosa by binding to ferrioxamine receptor FoxA, which disrupts the proton motive force to inhibit translation [ 113 ]. Hetiamacin E and F (39–40) ( Figure 10 ) produced from B. subtilis PJS display antibacterial activity against methicillin-resistant Staphylococcus aureus, with MIC values of 8–16 µg/mL and 32 µg/mL, respectively [ 114 ]. Hetiamacin E and F inhibit protein biosynthesis, resulting in the disruption of mRNA translation, leading to cell death [ 114 ].…”
Section: Antimicrobial Metabolites and Their Mechanism Of Actionmentioning
confidence: 99%
“…Hetiamacin E and F (39–40) ( Figure 10 ) produced from B. subtilis PJS display antibacterial activity against methicillin-resistant Staphylococcus aureus, with MIC values of 8–16 µg/mL and 32 µg/mL, respectively [ 114 ]. Hetiamacin E and F inhibit protein biosynthesis, resulting in the disruption of mRNA translation, leading to cell death [ 114 ]. Rhizocticin A (41) ( Figure 10 ) is a potent antifungal first produced from B. subtilis 6633.…”
Section: Antimicrobial Metabolites and Their Mechanism Of Actionmentioning
confidence: 99%
“…To combat the escalating levels of antibiotic resistance, novel strategies are being developed to address the ongoing demand for new natural antibiotics. The study by Wang et al, 2021 aimed to investigate amicoumacin antibiotics from the desert-derived Bacillus subtilis PJS by using the modern MS/MS-based molecular networking approach [ 15 ]. Hetiamacin E had strong antibacterial activity on methicillin-sensitive and -resistant Staphylococcus epidermidis at 2–4 µg/mL, and methicillin-sensitive and -resistant Staphylococcus aureus at 8–16 µg/mL.…”
mentioning
confidence: 99%